BEHANCE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

BEHANCE Trademark

Serial Number: 79188461 • Registration: 5225255

BEHANCE is a trademark filed by SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC, SociétéAnonyme on March 31, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC, SociétéAnonyme (2 trademarks)

75 quai d'Orsay
F-75007 PARIS , FR

Entity Type: 33

Trademark Details

Filing Date

March 31, 2016

Registration Date

June 20, 2017

Published for Opposition

April 4, 2017

Cancellation Date

January 5, 2024

Goods & Services

Dietetic products, namely, dietetic foods in the nature of pastas, crackers, and bread adapted for medical use; nutraceutical products, namely, nutraceuticals used as dietary supplements; food supplements for nutritional use; pharmaceutical preparations based on active ingredients for pharmaceutical use for the treatment of various medical conditions, namely, endocrinological conditions as well as other muscular conditions, namely, arthritis; dietetic food supplements containing active chemical ingredients; plant extracts for pharmaceutical use; food additives for pharmaceutical use, namely, glucose and lecithin for medical purposes

Biological substances, namely, biologically active enzymes and microorganisms of natural or synthetic origin for use in the manufacture of dietetic, nutraceutical, pharmaceutical or dermatological products; chemical substances in the nature of chemical preparations of natural or synthetic origin for the production of dietetic, nutraceutical, pharmaceutical or dermatological products; chemical products, namely, chemical preparations for use in the manufacture of nutraceutical, pharmaceutical or dermatological products; active ingredients, namely, active chemical ingredients for use in the manufacture of dietetic, nutraceutical, pharmaceutical or dermatological products

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Nov 23, 2024 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Sep 12, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 12, 2024 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 6, 2024 INTR
CANCELLED SECTION 71
Jan 5, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 20, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 13, 2017 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Sep 26, 2017 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 26, 2017 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 20, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 20, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2017 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Apr 1, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 15, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 15, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 22, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 21, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 21, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 21, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 21, 2017 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 17, 2017 TCCA
NON-FINAL ACTION MAILED
Feb 15, 2017 CNRT
NON-FINAL ACTION WRITTEN
Feb 14, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2017 TROA
REFUSAL PROCESSED BY IB
Aug 5, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 21, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jul 21, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 21, 2016 RFCR
NON-FINAL ACTION WRITTEN
Jul 20, 2016 CNRT
ASSIGNED TO EXAMINER
Jul 14, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 12, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 8, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 7, 2016 REPR